12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Phio Pharma PHIO shares increased by 27.6% to $4.3 during Tuesday's pre-market session. The company's market cap stands at $6.4 million. As per the news, the Q1 earnings report came out 3 days ago.
• YS Biopharma Co YS stock increased by 16.93% to $1.45. The company's market cap stands at $134.9 million.
• Nanobiotix NBTX shares rose 16.2% to $5.45. The market value of their outstanding shares is at $192.0 million.
• Coya Therapeutics COYA shares increased by 13.39% to $6.01. The company's market cap stands at $59.7 million. As per the press release, Q1 earnings came out 4 days ago.
• LumiraDx LMDX shares increased by 12.07% to $0.6. The market value of their outstanding shares is at $191.0 million. As per the press release, Q1 earnings came out today.
• Shuttle Pharmaceuticals SHPH shares increased by 12.03% to $1.21. The market value of their outstanding shares is at $16.5 million.

Losers

• Tivic Health Systems TIVC stock fell 28.1% to $0.14 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.0 million. As per the press release, Q1 earnings came out yesterday.
• Modular Medical MODD stock fell 27.51% to $0.91. The market value of their outstanding shares is at $9.9 million.
• Eloxx Pharmaceuticals ELOX stock declined by 26.61% to $8.0. The market value of their outstanding shares is at $17.3 million. As per the news, the Q1 earnings report came out yesterday.
• Horizon Therapeutics HZNP stock decreased by 17.73% to $92.35. The market value of their outstanding shares is at $21.1 billion.
• Perspective Therapeutics CATX shares fell 16.93% to $0.54. The company's market cap stands at $151.1 million. As per the press release, Q1 earnings came out yesterday.
• Calliditas Therapeutics CALT shares declined by 14.12% to $21.9. The market value of their outstanding shares is at $587.7 million. As per the press release, Q1 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.